Let-7, Mir-98 and Mir-181 as Biomarkers for Cancer and Schizophrenia

• Emmanouil Rizos ,

  * E-mail: erizos@med.uoa.gr

  Affiliation National and Kapodistrian University of Athens, Medical School, 2nd Department of Psychiatry, University “ATTIKON” General Hospital, Athens, Greece

  ⨯
• Nikolaos Siafakas,

  Affiliation National and Kapodistrian University of Athens, Medical School, Microbiology Laboratory, University “ATTIKON” General Hospital, Athens, Greece

  ⨯
• Eleni Katsantoni,

  Affiliation Biomedical Research Foundation, Academy of Athens, Hematology-Oncology Division, Athens, Greece

  ⨯
• Eleni Skourti,

  Affiliation Unit of Biomedical Applications, Institute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, Athens, Greece

  ⨯
• Vassilios Salpeas,

  Affiliation National & Kapodistrian University of Athens, 2nd Cardiology Department, University General Hospital “ATTIKON”, Athens, Greece

  ⨯
• Ioannis Rizos,

  Affiliation National & Kapodistrian University of Athens, 2nd Cardiology Department, University General Hospital “ATTIKON”, Athens, Greece

  ⨯
• James N. Tsoporis,

  Affiliation Keenan Research Centre. Li Ka Shing Knowledge Institute for Biomedical Science, St. Michael’s Hospital, Toronto, Canada

  ⨯
• Anastasia Kastania,

  Affiliation Department of Informatics, Athens University of Economics and Business, Athens, Greece

  ⨯
• Anastasia Filippopoulou,

  Affiliations National and Kapodistrian University of Athens, Medical School, 2nd Department of Psychiatry, University “ATTIKON” General Hospital, Athens, Greece, Medical School, Democritus University of Thrace, University General Hospital of Alexandroupolis, Department of Psychiatry, Alexandroupolis, Greece

  ⨯
• Nikolaos Xiros,

  Affiliation Second Department of Propaedeutic Internal Medicine, Oncology Unit, Attikon University Hospital, Athens, Greece

  ⨯
• Demetrios Margaritis,

  Affiliation National and Kapodistrian University of Athens, Medical School, 2nd Department of Psychiatry, University “ATTIKON” General Hospital, Athens, Greece

  ⨯
• Thomas G. Parker,

  Affiliation Keenan Research Centre. Li Ka Shing Knowledge Institute for Biomedical Science, St. Michael’s Hospital, Toronto, Canada

  ⨯
• Charalabos Papageorgiou,

  Affiliation National and Kapodistrian University of Athens, Medical School, 2nd Department of Psychiatry, University “ATTIKON” General Hospital, Athens, Greece

  ⨯
• Vassilios Zoumpourlis

  Affiliation Unit of Biomedical Applications, Institute of Biology, Medicinal Chemistry & Biotechnology, National Hellenic Research Foundation, Athens, Greece

  ⨯